EF-CBP2 Activators
EF-CBP2 Activators are a class of compounds that exert their effects through the modulation of second messenger systems, primarily targeting cyclic nucleotide pathways. Forskolin, by activating adenylyl cyclase, and Isoproterenol, an adrenergic agonist, both work to increase intracellular levels of cAMP, a pivotal messenger in cellular signaling pathways. The raised cAMP levels activate protein kinase A (PKA), which is known to phosphorylate a wide array of proteins. It is through this PKA activation that EF-CBP2 may be phosphorylated, thereby enhancing its functional activity within the cell. Similarly, Dibutyryl-cAMP, a membrane-permeable cAMP analog, directly stimulates PKA, potentially leading to EF-CBP2 activation in a more direct fashion.
On another front, the modulation of calcium signaling is another potential route to activate EF-CBP2. Compounds such as A23187 and Thapsigargin disrupt calcium homeostasis within the cell. A23187 acts as a calcium ionophore, facilitating the influx of calcium ions, while Thapsigargin inhibits the SERCA pump, leading to an increase in cytosolic calcium levels. This build-up of intracellular calcium can activate calcium/calmodulin-dependent protein kinases (CaMKs), which then may phosphorylate and activate EF-CBP2. The interplay between cAMP/PKA and calcium/CaMK signaling offers a rich landscape for EF-CBP2 activation, with these compounds providing the chemical basis for indirectly enhancing the activity of EF-CBP2 through specific cellular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cAMP levels, which can enhance PKA activity that may phosphorylate and activate EF-CBP2. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP degradation, potentially maintaining PKA activity that could phosphorylate EF-CBP2. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
Substrate for NO synthase, increasing NO production which can activate sGC and raise cGMP levels, indirectly enhancing the activity of EF-CBP2 through cGMP-dependent pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Adrenergic receptor agonist that increases intracellular cAMP, potentially enhancing PKA activity to activate EF-CBP2. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that raises cAMP levels, which may lead to PKA-mediated phosphorylation of EF-CBP2. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium levels, possibly promoting CaMK activation that could phosphorylate and activate EF-CBP2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that raises cytosolic calcium levels, which could enhance the activity of calcium-dependent kinases that activate EF-CBP2. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of EF-CBP2. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
sGC activator that raises cGMP levels, which may support the activation of EF-CBP2 through cGMP-dependent pathways. | ||||||
Loprinone Hydrochloride | 119615-63-3 | sc-207832 | 10 mg | $330.00 | ||
PDE3 inhibitor that increases cAMP levels, potentially promoting PKA activity that could lead to the phosphorylation and functional enhancement of EF-CBP2. | ||||||